Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

101.90
CHF
+49.04
(+92.78%)
3.36EPS
Feb 23Next Earn

Halozyme Therapeutics, Inc. Documents

Q1 FY2024 · Press release

June 6, 2024 · 2 pages

Read Halozyme Therapeutics, Inc.'s results firsthand

Preview this press release
Create a free account to start reading

Full documents are included with Professional

Q1 FY2024 documents